SARCLISA

Google image searchProduct monograph

Active ingredient

isatuximab, 500 MG/25 ML

DIN: 02498243

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIALS. FOR I.V. INFUSION

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 03-JUL-2020

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FC — CD38 (Clusters of Differentiation 38) inhibitors (ATC, ATC/DDD)
• L01FC02 — ISATUXIMAB (ATC/DDD)

External Links for Sarclisa

Search on Google

• Sarclisa side effects
• Sarclisa dosage
• isatuximab side effects
• isatuximab dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find sarclisa photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.